User profiles for John Tazare

John Tazare

London School of Hygiene & Tropical Medicine
Verified email at lshtm.ac.uk
Cited by 1528

[HTML][HTML] Factors that influence vaccination decision-making among pregnant women: A systematic review and meta-analysis

E Kilich, S Dada, MR Francis, J Tazare, RM Chico… - PloS one, 2020 - journals.plos.org
Background The most important factor influencing maternal vaccination uptake is healthcare
professional (HCP) recommendation. However, where data are available, one-third of …

[HTML][HTML] Case fatality risk of the SARS-CoV-2 variant of concern B. 1.1. 7 in England, 16 November to 5 February

…, S Harper, NJ DeVito, W Hulme, J Tazare… - …, 2021 - eurosurveillance.org
The SARS-CoV-2 B.1.1.7 variant of concern (VOC) is increasing in prevalence across Europe.
Accurate estimation of disease severity associated with this VOC is critical for pandemic …

[HTML][HTML] Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study

KE Mansfield, R Mathur, J Tazare… - The Lancet Digital …, 2021 - thelancet.com
Background There are concerns that the response to the COVID-19 pandemic in the UK might
have worsened physical and mental health, and reduced use of health services. However, …

Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform

…, HJ Curtis, H Forbes, K Wing, C Minassian, J Tazare… - bmj, 2021 - bmj.com
Objective To assess the association between learning disability and risk of hospital admission
and death from covid-19 in England among adults and children. Design Population based …

[HTML][HTML] Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in …

…, W Hulme, C Bates, HJ Curtis, J Tazare… - The Lancet …, 2022 - thelancet.com
Background The risk of severe COVID-19 outcomes in people with immune-mediated
inflammatory diseases and on immune-modifying drugs might not be fully mediated by …

Severity of severe acute respiratory system coronavirus 2 (SARS-CoV-2) alpha variant (B. 1.1. 7) in England

…, NJ DeVito, W Hulme, J Tazare… - Clinical Infectious …, 2022 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) alpha
variant (B.1.1.7) is associated with higher transmissibility than wild-type virus, becoming the …

Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY

…, K Wing, AYS Wong, H Forbes, J Tazare… - British Journal of …, 2021 - bjgp.org
Background Long COVID describes new or persistent symptoms at least 4 weeks after onset
of acute COVID-19. Clinical codes to describe this phenomenon were recently created. Aim …

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the …

B Zheng, ACA Green, J Tazare, HJ Curtis, L Fisher… - bmj, 2022 - bmj.com
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …

[HTML][HTML] Survival outcomes and prognostic factors in glioblastoma

NF Brown, D Ottaviani, J Tazare, J Gregson, N Kitchen… - Cancers, 2022 - mdpi.com
Simple Summary Glioblastoma is the most common tumour that originates in the brain in
adults. Most of the published data on glioblastoma are from patients in clinical trials who tend to …

[HTML][HTML] OpenSAFELY: Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England

…, A Schultze, H Curtis, W Hulme, J Tazare… - Wellcome Open …, 2022 - ncbi.nlm.nih.gov
Background: Since its inception in March 2020, data from the OpenSAFELY-TPP electronic
health record platform has been used for more than 20 studies relating to the global COVID-…